Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.96%16.91B | -4.92%53.69B | -7.34%39.86B | -9.96%28.15B | -10.96%16.75B | -16.38%56.47B | -15.38%43.02B | -12.81%31.26B | -9.45%18.81B | 24.08%67.54B |
| Operating income | 0.96%16.91B | -4.92%53.69B | -7.34%39.86B | -9.96%28.15B | -10.96%16.75B | -16.38%56.47B | -15.38%43.02B | -12.81%31.26B | -9.45%18.81B | 24.08%67.54B |
| Cost of sales | ---- | 6.35%-36.64B | ---- | 8.85%-19.16B | ---- | 16.19%-39.13B | ---- | 16.26%-21.02B | ---- | -17.98%-46.69B |
| Operating expenses | 0.03%-11.22B | 6.35%-36.64B | 6.54%-26.89B | 8.85%-19.16B | 10.51%-11.22B | 16.19%-39.13B | 17.08%-28.77B | 16.26%-21.02B | 14.94%-12.54B | -17.98%-46.69B |
| Gross profit | 2.96%5.69B | -1.70%17.05B | -8.96%12.97B | -12.23%8.99B | -11.85%5.52B | -16.81%17.35B | -11.71%14.25B | -4.76%10.24B | 4.00%6.26B | 40.33%20.85B |
| Selling expenses | 7.22%-2.04B | 3.85%-9.67B | 4.98%-6.46B | 8.11%-4.79B | 8.99%-2.2B | 6.39%-10.06B | 2.08%-6.8B | -3.41%-5.22B | -17.90%-2.41B | -117.13%-10.74B |
| Administrative expenses | -7.49%-454.81M | -10.02%-2.57B | 7.05%-1.32B | 7.00%-1.04B | 11.04%-423.12M | 10.04%-2.34B | 7.91%-1.42B | 7.67%-1.12B | -6.54%-475.64M | -1.10%-2.6B |
| Research and development expenses | 76.19%-2.9M | -352.74%-89.98M | -675.28%-67.69M | -4,145.81%-38.47M | -3,327.00%-12.17M | 65.98%-19.87M | 10.72%-8.73M | -9.82%-906K | 49.22%-355K | -49.69%-58.42M |
| Profit from asset sales | 21,506.96%3.19M | ---- | 222.77%47.67M | ---- | 99.02%-14.9K | ---- | 1,259.31%14.77M | ---- | -673.05%-1.52M | ---- |
| Impairment and provision | 52.30%-60.6M | -231.56%-3.5M | 1.23%-380.78M | -164.43%-1.45M | 13.69%-127.03M | 3.30%2.66M | 18.66%-385.53M | -40.27%2.25M | -5.16%-147.19M | -64.00%2.58M |
| -Other impairment is provision | 52.30%-60.6M | -231.56%-3.5M | 1.23%-380.78M | -164.43%-1.45M | 13.69%-127.03M | 3.30%2.66M | 18.66%-385.53M | -40.27%2.25M | -5.16%-147.19M | -64.00%2.58M |
| Special items of operating profit | 47.74%-10.24M | -37.91%929.12M | -82.42%20.27M | -6.84%693.97M | -186.10%-19.6M | 0.27%1.5B | 68.11%115.3M | 16.97%744.89M | 29.38%22.76M | 255.24%1.49B |
| Operating profit | 13.21%2.62B | -12.21%5.65B | -19.03%3.89B | -18.15%3.8B | -16.80%2.32B | -28.12%6.43B | -19.80%4.8B | -9.43%4.65B | -2.12%2.78B | 15.75%8.95B |
| Financing income | -20.24%189.69M | ---- | -15.96%651.93M | ---- | -8.49%237.83M | ---- | 20.72%775.76M | ---- | 79.93%259.9M | ---- |
| Financing cost | 19.11%-51.79M | 11.89%-178.42M | 8.41%-136.79M | 9.92%-88.19M | 7.95%-64.03M | 32.02%-202.5M | 27.26%-149.34M | 39.26%-97.9M | -9.98%-69.55M | -53.41%-297.89M |
| Share of profits of associates | ---- | -572.68%-64.98M | ---- | -150.42%-12.53M | ---- | -87.45%13.75M | ---- | 3.43%24.85M | ---- | -33.58%109.56M |
| Share of profit from joint venture company | ---- | -28.75%-25.61M | ---- | -299.35%-7.97M | ---- | -63.47%-19.89M | ---- | -224.44%-2M | ---- | -396.41%-12.17M |
| Special items of earning before tax | 861.51%2.39M | ---- | -511.35%-66.93M | ---- | -126.48%-314.16K | ---- | -649.94%-10.95M | ---- | -45.34%1.19M | ---- |
| Earning before tax | 11.00%2.8B | -13.58%5.38B | -18.89%4.42B | -19.18%3.7B | -13.44%2.52B | -28.85%6.22B | -17.13%5.45B | -8.48%4.57B | -7.81%2.91B | 13.62%8.75B |
| Tax | ---- | -24.62%-1.63B | ---- | 15.55%-765.45M | ---- | 6.72%-1.31B | ---- | -5.41%-906.37M | ---- | 1.92%-1.4B |
| After-tax profit from continuing operations | 15.30%2.37B | -23.74%3.75B | -19.66%3.46B | -20.08%2.93B | -15.58%2.06B | -33.08%4.92B | -20.51%4.31B | -11.36%3.67B | -1.25%2.44B | 17.16%7.35B |
| Earning after tax | 15.30%2.37B | -23.74%3.75B | -19.66%3.46B | -20.08%2.93B | -15.58%2.06B | -33.08%4.92B | -20.51%4.31B | -11.36%3.67B | -1.25%2.44B | 17.16%7.35B |
| Minority profit | -81.33%22.02M | -82.11%106.24M | 5.08%411.75M | -14.55%308.48M | -8.40%117.93M | 6.45%593.91M | 80.63%391.83M | 57.55%361M | -22.06%128.75M | -51.82%557.91M |
| Profit attributable to shareholders | 21.18%2.35B | -15.72%3.64B | -22.13%3.05B | -20.68%2.62B | -15.98%1.94B | -36.32%4.32B | -24.72%3.92B | -15.40%3.31B | 0.25%2.31B | 32.77%6.79B |
| Basic earnings per share | 21.18%1.1351 | -15.72%1.7613 | -22.13%1.4752 | -20.68%1.2673 | -15.98%0.9367 | -36.32%2.0899 | -24.72%1.8944 | -15.40%1.5978 | -15.09%1.1148 | 27.72%3.282 |
| Diluted earnings per share | 21.18%1.1351 | -15.72%1.7613 | -22.13%1.4752 | -20.68%1.2673 | -15.98%0.9367 | -36.32%2.0899 | -24.72%1.8944 | -15.40%1.5978 | -15.09%1.1148 | 27.72%3.282 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.